DBS CEO Tan Su Shan named 6th most powerful woman in business in Fortune's list
DBS CEO Tan Su Shan is the only Singaporean in the top 10 and one of three Singapore-based leaders in the list. ST PHOTO: KEVIN LIM
SINGAPORE - DBS Bank chief executive Tan Su Shan has been named the sixth most powerful woman in business in Fortune magazine's 100 Most Powerful Women in Business list in 2025.
Ms Tan, 57, is the only Singaporean in the top 10 and one of three Singapore-based leaders in the list, which was released on May 20. She jumped from 89th place on the magazine's list in 2024, when she was serving as DBS's deputy CEO.
She is also one of the two Asia-based leaders in the top 10 – tech giant Huawei chief financial officer Meng Wanzhou is at No. 10.
On the list, OCBC Bank CEO Helen Wong ranked 15th and Temasek's chief financial officer Png Chin Yee was 87th.
The list is based on company size and health, as well as an executive's career trajectory, influence, innovation, and efforts to make business better, said Fortune.
Ms Tan is the first female CEO in DBS's history. She took over the helm from Mr Piyush Gupta, who stepped down in March after a 15-year stint.
Ms Tan joined DBS, South-east Asia's largest bank, in 2010. Prior to taking on the CEO role, she led DBS's institutional banking division and helped expand the bank's consumer banking, wealth management and international banking businesses.
Before joining DBS, she was Morgan Stanley's head of private wealth management for South-east Asia. She has also worked at Citibank and prior to that, at ING Barings.
US leaders occupied six of the names on the top 10 list. Ms Mary Barra, CEO of General Motors, is at No. 1. Accenture CEO Julie Sweet ranked second while Citigroup CEO Jane Fraser took the third spot. In fourth place was AMD CEO Lisa Su and Banco Santander's executive chairman Ana Botín, one of two Spanish leaders in the top 10, was ranked fifth.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
an hour ago
- CNA
Lawrence Wong to make first visit to China as prime minister, meet with Li Qiang and Xi Jinping in Beijing
SINGAPORE: Prime Minister Lawrence Wong will visit China from Jun 22 to Jun 26 and meet Chinese Premier Li Qiang and President Xi Jinping in Beijing. This will be Mr Wong's first visit to China as Singapore's prime minister, and both sides will commemorate the 35th anniversary of the establishment of diplomatic relations between Singapore and China. 'It is also an opportunity for leaders on both sides to exchange views on bilateral issues as well as regional and international developments,' said the Prime Minister's Office in a statement on Sunday (Jun 22). Mr Wong last met Mr Li and Mr Xi respectively in October and November 2024 on the sidelines of multilateral meetings. He last visited China in December 2023 as deputy prime minister for the 19th Joint Council for Bilateral Cooperation. This time, he will meet Mr Xi, and be hosted to a welcome ceremony and a dinner banquet by Mr Li. He will also meet Mr Zhao Leji, chairman of the National People's Congress In Beijing, Mr Wong will also engage Singaporeans in the Chinese capital at a reception. In Tianjin, the Prime Minister will attend the World Economic Forum's (WEF) Annual Meeting of New Champions, often referred to as Summer Davos, and take part in a dialogue session with WEF president Borge Brende. Mr Wong will also attend an official dinner hosted by Mr Li for foreign leaders attending Summer Davos. On this trip, he will be accompanied by Minister for Foreign Affairs Vivian Balakrishnan, Minister for Sustainability and the Environment and Minister-in-charge of Trade Relations Grace Fu and Acting Minister for Transport and Senior Minister of State for Finance Jeffrey Siow. Senior Minister of State for Foreign Affairs and for Home Affairs Sim Ann, Senior Parliamentary Secretary Syed Harun Alhabsyi and other government officials will also be part of the contingent. Mr Wong will conclude his trip on Jun 26 and be on leave on Jun 27. In his absence, Deputy Prime Minister and Minister for Trade and Industry Gan Kim Yong will be Acting Prime Minister from Jun 22 to Jun 25, while Minister for Home Affairs K Shanmugam will take on the role from Jun 26 to Jun 27.
Business Times
an hour ago
- Business Times
Despite softer retail outlook, most S-Reits with Singapore retail assets record double-digit positive rent reversions
[SINGAPORE] Seven Singapore-listed real estate investment trusts (S-Reits) with local retail assets have recorded improvements in revenue and net property income (NPI), supported by improved operating metrics, positive rental reversions and robust occupancy rates. They are: CapitaLand Integrated Commercial Trust (CICT), Frasers Centrepoint Trust (FCT), Lendlease Global Commercial Reit (L-Reit), Mapletree Pan Asia Commercial Trust (MPACT), OUE Reit , Starhill Global Reit and Suntec Reit . Here is a look at their recent business updates and financials. CICT reported a slight 0.8 per cent year-on-year (yoy) decline in both revenue and NPI for the first quarter of 2025, due to the absence of income from 21 Collyer Quay, which was divested in November 2024. Excluding the divested asset, revenue and NPI were up by 1.1 per cent and 1.4 per cent, respectively. CICT's retail portfolio recorded a 17.5 per cent yoy growth in tenant sales, with shopper traffic rising by 23 per cent. The portfolio's rent reversion was 10.4 per cent, with higher rates in downtown malls compared with suburban ones. The trust expects positive rent reversions signed in FY2023 and FY2024 leases to contribute to FY2025 revenue, along with the full-year distribution income from Ion Orchard, acquired in September 2024. FCT reported increases in revenue and NPI of 7.1 per cent and 7.3 per cent, respectively, for the first half of 2025, driven by higher rental income from renewed and new leases. Its portfolio maintained a committed occupancy of 99.5 per cent. Shopper traffic and tenant sales were up by 1 per cent and 3.3 per cent, respectively, yoy. A NEWSLETTER FOR YOU Tuesday, 12 pm Property Insights Get an exclusive analysis of real estate and property news in Singapore and beyond. Sign Up Sign Up Overall rent reversion for the period was positive at 9 per cent. FCT's Hougang Mall property commenced asset-enhancement initiative (AEI) works in April 2025, which are expected to be completed by Q3 2026. The expected return on investment is around 7 per cent, on S$51 million in capital expenditure. At present, 64 per cent of the AEI spaces have been pre-committed. L-Reit reported that its Singapore portfolio, comprising around 90 per cent of its total portfolio by valuation, achieved positive retail rent reversion of 10.4 per cent despite a softer retail landscape. Committed occupancy for Jem and 313@somerset remained high at 99.9 per cent and 98.9 per cent, respectively. MPACT recorded lower revenue and NPI for FY2024/2025, down by 5.1 per cent and 6.1 per cent, respectively, yoy. However, revenue and NPI from MPACT's Singapore portfolio rose by 1 per cent and 1.1 per cent, respectively, driven by VivoCity. Despite disruptions from ongoing AEI works, the mall recorded full-year tenant sales that crossed the S$1 billion mark for a third consecutive year. MPACT achieved 89.6 per cent committed occupancy as at Mar 31, and it recorded a 3.6 per cent rental uplift overall, with VivoCity alone seeing a robust 16.8 per cent rent reversion. OUE Reit's retail segment contributes 16.8 per cent of its overall revenue. Its Mandarin Gallery asset maintained a 99.5 per cent committed occupancy as at Mar 31, and recorded 4.9 per cent positive rent reversion in Q1. Starhill Global Reit reported full occupancy as at Mar 31 for its Singapore retail portfolio. Its overall portfolio has a weighted average lease term expiry of 7.2 years by net lettable area, with more than 64 per cent of leases expiring beyond FY2027/2028. The Reit's Singapore retail properties include a 71.49 per cent stake in Wisma Atria and a 27.23 per cent stake in Ngee Ann City. The Reit renewed its master lease with Takashimaya manager Toshin Development Singapore – which commenced on Jun 8 – for an initial term of 12 years, with further renewal options. The new master lease includes built-in rent escalations and an annual profit-sharing arrangement, providing upside for the Reit. Suntec Reit's Singapore retail portfolio recorded improved committed occupancy of 98.2 per cent as at Mar 31, compared to 95.8 per cent in the year-ago period. Rent reversion for its Singapore retail properties was 10.3 per cent, with a 91 per cent retention rate. The writer is a research analyst at SGX. For more research and information on Singapore's Reit sector, visit for the S-Reits & Property Trusts Chartbook.
Business Times
an hour ago
- Business Times
SunMoon Food CEO Zhang Ye boosts interests
[SINGAPORE] Over the four trading sessions from Jun 13 to 18, institutions were net sellers of Singapore stocks, with net institutional outflow of S$42 million following the S$80 million net outflow in the preceding five sessions. This takes the net institutional outflow for the year to Jun 18 to S$1.88 billion. Institutional flows In the four trading sessions, the stocks with the highest net institutional outflow were DBS , Singapore Airlines (SIA), Wilmar International , Singtel , OCBC , Sats , Mapletree Industrial Trust , UOL , Riverstone , and DFI Retail Group . Meanwhile, Keppel , Singapore Exchange (SGX), ST Engineering , CapitaLand Integrated Commercial Trust , Yangzijiang Shipbuilding , Jardine Matheson , Mapletree Logistics Trust , Rex International , Hongkong Land , and Seatrium led the net institutional inflow over the four sessions. From a sector perspective, financial services and consumer non-cyclicals experienced the highest net institutional outflow, while industrials and real estate investment trusts (Reits) had the most net institutional inflow. Singtel leads net institutional inflows in Q2 2025 Institutions were net sellers for much of the second quarter of 2025, but sector flows were mixed, with financial services and Reits seeing the largest outflows, while telecommunications and industrials – led by Singtel, SIA, Keppel, and ST Engineering – recorded notable inflows. From end-2023 to Jun 18, Singtel led net institutional inflows into the local market with S$1.6 billion, while its Straits Times Index weight rose from 6 per cent to 8 per cent. Its total return ranked it as the second-best performer in the Dow Jones Sector Titans Telecommunication Index. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Earlier this month, Gerald Wong, founder of financial advisory platform Beansprout, interviewed Singtel's group chief financial officer Arthur Lang to discuss the company's recent momentum. Lang noted that profit growth in FY2025 was driven by strong execution across core business units, with subsidiaries Optus and NCS achieving earnings before interest and taxes expansion of 55 per cent and 39 per cent, respectively. He also highlighted the 'Singtel28' strategy's focus on lifting business performance by strengthening the company's core connectivity businesses, and scaling growth areas such as IT services and digital infrastructure. For instance, its data centre arm, Nxera, is expanding rapidly with support from a partnership with KKR, enabling regional growth with partial funding from external capital. Lang also highlighted that longstanding regional partnerships and active capital management to fund growth and boost shareholder returns continue to position Singtel for long-term resilience. Share buybacks In the four sessions, 15 primary-listed companies made buybacks with a total consideration of S$61.8 million. DBS, UOB and OCBC again led the consideration tally, collectively buying back S$58.9 million of shares. On their current buyback mandates, UOB has bought back 0.35 per cent of its outstanding shares, DBS has repurchased 0.22 per cent, and OCBC has bought back 0.06 per cent, as at Jun 18. Secondary-listed Hongkong Land also continued to conduct share repurchases over the four sessions. Director transactions The four trading sessions saw a bit of a pause in director interests and substantial shareholdings filings. There were fewer than 40 filings for 20 primary-listed stocks. Directors or chief executive officers filed six acquisitions and two disposals, while substantial shareholders filed one acquisition and two disposals. These included director or CEO acquisitions in CosmoSteel , Hyphens Pharma International , Mencast and SunMoon Food Company . CosmoSteel On Jun 13, CosmoSteel executive director and CEO Jack Ong acquired two million shares at an average price of S$0.22 each, boosting his direct interest from 17.39 per cent to 18.15 per cent. On May 15, Evolve Capital Advisory, on behalf of 3HA Capital, announced a voluntary conditional cash offer for all issued and paid-up ordinary shares of CosmoSteel at S$0.20 apiece. The offer has drawn scrutiny from significant shareholders the Ong family, who have requested clarifications. Prior to the development, CosmoSteel's CEO had also raised his direct interest from 14.5 per cent. SunMoon Food Company Between Jun 13 and 18, SunMoon Food Company executive director and CEO Zhang Ye acquired 3,099,100 shares at S$0.16 apiece. This increased his total interest from 51.77 per cent to 52.12 per cent. He has been gradually increasing his total interest from 51.57 per cent May 27, when the group reported its FY2024/2025 (ended Mar 31) results. He was appointed CEO and executive director in December 2018. The serial entrepreneur also founded Yiguo – China's first fresh food e-commerce platform – and Enmore Group, which is now a leading player in China's bulk chemical services sector. For FY2024/2025, SunMoon Food Company reported revenue of S$33.83 million, up from S$27.06 million the previous year. The growth was driven by stronger sales of fruits, aquatic foods, and non-hazardous chemical products. The group generated 93 per cent of its revenue for the period from China, with the remainder coming from Asean. Its gross profit for FY2024/2025 remained steady at S$821,000, though the margin declined to 2.43 per cent from 3.03 per cent in FY2023/2024, due mainly to the clearance of slow-moving inventory sold at minimal or negative margins. The company said it is working to enhance profitability by expanding its non-hazardous chemical segment through strategic partnerships. It also remains focused on growing cross-border trade – exporting food products from China to South-east Asia, and importing basa fish (a freshwater fish native to South-east Asia) into China. Hyphens Pharma International On Jun 16, Hyphens Pharma International non-executive director Tan Kia King acquired 33,600 shares at S$0.30 apiece. This grew his total interest incrementally, from 28.13 per cent to 28.14 per cent. The open market purchase followed his acquisitions of 100,000 shares in May and 88,000 shares in April, with both transactions at S$0.285 per share. Appointed in December 2017, Dr Tan brings more than 30 years of medical and leadership experience to the group, including roles as managing director of Westpoint Family Hospital and chairman of Taka Jewellery. Hyphens Pharma International is headquartered in Singapore with direct operations in Indonesia, Malaysia, the Philippines and Vietnam. Its foundation dates back to 1998, when current chairman and CEO Lim See Wah invested in Pan-Malayan Pharmaceuticals, laying the groundwork for a regional healthcare platform. Established in the 1940s, Pan-Malayan is Singapore's oldest pharmaceutical wholesaler, with a rich history of supplying clinics, pharmacies, hospitals, nursing homes and trade partners. In 2002, Lim bought into Hyphens Pharma. The move unlocked Asean expansion and proprietary innovation, including the launch of Ceradan – a therapeutic skincare brand – and strategic research and development with the Agency for Science, Technology and Research. Hyphens Pharma International listed on the SGX Catalist in 2018. With a growing regional footprint, it continues to champion Asia's role in healthcare innovation. The group currently comprises five key entities: Hyphens Pharma, DocMed Technology, Ocean Health, Novem and Ardence Pharma. They advance the three core segments of speciality pharmaceuticals; proprietary brands; as well as medical hypermart and digital. In FY2024 (ended Dec 31), the group reported record revenue of S$195.4 million and a net profit after tax of S$10.9 million. It remains focused on scaling its core segments, with proprietary brands expanding regionally and speciality pharmaceuticals advancing through new launches and exclusive rights. It also continues to strategically enhance longstanding assets such as Pan-Malayan and online marketplace POM, with a focus on building high-traffic digital platforms to unlock greater value. Part of DocMed Technology, POM is a business-to-business pharmaceutical marketplace that operates in Singapore, Malaysia and Vietnam. Hyphens Pharma International maintains a market capitalisation of nearly S$100 million, with a return on equity ratio of 15.2 per cent, dividend yield of 4.8 per cent, and price-to-earnings ratio of 9.6 times as at last week. The counter is also among the 10 SGX-listed healthcare stocks that have booked the highest net institutional inflows in the first half of 2025. In April, Evolve Capital initiated coverage on Hyphens Pharma International with a target price of S$0.365. The advisory platform noted that despite its smaller scale, Hyphens Pharma International maintains decent margins, a net cash position, and consistent revenue growth, making its low valuation unjustified. While near-term growth may moderate, Evolve Capital expects continued portfolio expansion across the segments of speciality pharmaceuticals and proprietary brands. Buybacks and director transactions for Jun 19 will be included next week. The writer is the market strategist at SGX. To read SGX's market research reports, visit
